nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—MTHFR—Fluorouracil—skin cancer	0.297	0.421	CbGbCtD
Menadione—CYP1A2—Imiquimod—skin cancer	0.0902	0.128	CbGbCtD
Menadione—CYP1A1—Dacarbazine—skin cancer	0.0848	0.12	CbGbCtD
Menadione—CYP2E1—Dacarbazine—skin cancer	0.0655	0.0929	CbGbCtD
Menadione—CYP2A6—Fluorouracil—skin cancer	0.0582	0.0825	CbGbCtD
Menadione—CYP1A2—Vemurafenib—skin cancer	0.0494	0.0701	CbGbCtD
Menadione—CYP1A2—Dacarbazine—skin cancer	0.0379	0.0537	CbGbCtD
Menadione—CYP1A2—Fluorouracil—skin cancer	0.0222	0.0315	CbGbCtD
Menadione—BGLAP—forelimb zeugopod—skin cancer	0.0178	0.0807	CbGeAlD
Menadione—NQO1—Dopamine metabolism—TYR—skin cancer	0.0115	0.155	CbGpPWpGaD
Menadione—MAOB—Dopamine metabolism—TYR—skin cancer	0.00935	0.126	CbGpPWpGaD
Menadione—BGLAP—leg—skin cancer	0.00901	0.0409	CbGeAlD
Menadione—BGLAP—forelimb—skin cancer	0.00894	0.0406	CbGeAlD
Menadione—BGLAP—hindlimb—skin cancer	0.00804	0.0365	CbGeAlD
Menadione—BGLAP—arm—skin cancer	0.00768	0.0348	CbGeAlD
Menadione—F7—endothelium—skin cancer	0.00713	0.0324	CbGeAlD
Menadione—BGLAP—appendage—skin cancer	0.0069	0.0313	CbGeAlD
Menadione—F9—endothelium—skin cancer	0.00682	0.0309	CbGeAlD
Menadione—F7—blood vessel—skin cancer	0.00658	0.0298	CbGeAlD
Menadione—F9—blood vessel—skin cancer	0.00629	0.0285	CbGeAlD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—KRT17—skin cancer	0.00568	0.0765	CbGpPWpGaD
Menadione—F2—leg—skin cancer	0.0056	0.0254	CbGeAlD
Menadione—F2—forelimb—skin cancer	0.00556	0.0252	CbGeAlD
Menadione—F2—hindlimb—skin cancer	0.005	0.0227	CbGeAlD
Menadione—F2—appendage—skin cancer	0.00429	0.0195	CbGeAlD
Menadione—PROS1—hair follicle—skin cancer	0.0038	0.0172	CbGeAlD
Menadione—F7—connective tissue—skin cancer	0.00337	0.0153	CbGeAlD
Menadione—F9—connective tissue—skin cancer	0.00322	0.0146	CbGeAlD
Menadione—VKORC1—blood vessel—skin cancer	0.00321	0.0146	CbGeAlD
Menadione—F9—epithelium—skin cancer	0.00306	0.0139	CbGeAlD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—KRT5—skin cancer	0.00298	0.0402	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—KRT14—skin cancer	0.00277	0.0373	CbGpPWpGaD
Menadione—BGLAP—neck—skin cancer	0.00275	0.0125	CbGeAlD
Menadione—MTHFR—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00263	0.0354	CbGpPWpGaD
Menadione—F2—endothelium—skin cancer	0.00259	0.0117	CbGeAlD
Menadione—PROS1—nipple—skin cancer	0.00257	0.0117	CbGeAlD
Menadione—F7—lymphoid tissue—skin cancer	0.00247	0.0112	CbGeAlD
Menadione—F10—nipple—skin cancer	0.00242	0.011	CbGeAlD
Menadione—F2—blood vessel—skin cancer	0.00239	0.0108	CbGeAlD
Menadione—MTHFR—blood vessel—skin cancer	0.00239	0.0108	CbGeAlD
Menadione—F7—female reproductive system—skin cancer	0.00238	0.0108	CbGeAlD
Menadione—F9—lymphoid tissue—skin cancer	0.00236	0.0107	CbGeAlD
Menadione—F9—female reproductive system—skin cancer	0.00227	0.0103	CbGeAlD
Menadione—VKORC1L1—female reproductive system—skin cancer	0.00224	0.0102	CbGeAlD
Menadione—F7—head—skin cancer	0.00199	0.00902	CbGeAlD
Menadione—BGLAP—connective tissue—skin cancer	0.00197	0.00893	CbGeAlD
Menadione—F9—head—skin cancer	0.0019	0.00862	CbGeAlD
Menadione—BGLAP—Regulation of retinoblastoma protein—MITF—skin cancer	0.0019	0.0255	CbGpPWpGaD
Menadione—VKORC1L1—head—skin cancer	0.00187	0.0085	CbGeAlD
Menadione—PROS1—connective tissue—skin cancer	0.00183	0.00828	CbGeAlD
Menadione—MAOB—nerve—skin cancer	0.00179	0.00813	CbGeAlD
Menadione—NQO2—nipple—skin cancer	0.00172	0.0078	CbGeAlD
Menadione—F2—neck—skin cancer	0.00171	0.00775	CbGeAlD
Menadione—MTHFR—neck—skin cancer	0.00171	0.00775	CbGeAlD
Menadione—GGCX—mammalian vulva—skin cancer	0.00158	0.00718	CbGeAlD
Menadione—F2—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.00151	0.0203	CbGpPWpGaD
Menadione—PROS1—mammalian vulva—skin cancer	0.0015	0.00682	CbGeAlD
Menadione—CYP1A1—skin epidermis—skin cancer	0.00148	0.0067	CbGeAlD
Menadione—NQO1—nipple—skin cancer	0.00144	0.00653	CbGeAlD
Menadione—NQO1—neck—skin cancer	0.00142	0.00646	CbGeAlD
Menadione—F10—mammalian vulva—skin cancer	0.00141	0.00642	CbGeAlD
Menadione—BGLAP—female reproductive system—skin cancer	0.00139	0.0063	CbGeAlD
Menadione—GGCX—female reproductive system—skin cancer	0.00136	0.00615	CbGeAlD
Menadione—AOX1—nipple—skin cancer	0.00132	0.00599	CbGeAlD
Menadione—VKORC1L1—lymph node—skin cancer	0.00131	0.00595	CbGeAlD
Menadione—PROS1—female reproductive system—skin cancer	0.00129	0.00584	CbGeAlD
Menadione—F7—Circadian rythm related genes—NKX2-1—skin cancer	0.00128	0.0173	CbGpPWpGaD
Menadione—F2—connective tissue—skin cancer	0.00122	0.00555	CbGeAlD
Menadione—XDH—mammalian vulva—skin cancer	0.00121	0.00551	CbGeAlD
Menadione—F10—female reproductive system—skin cancer	0.00121	0.0055	CbGeAlD
Menadione—F2—epithelium—skin cancer	0.00116	0.00527	CbGeAlD
Menadione—VKORC1—female reproductive system—skin cancer	0.00116	0.00527	CbGeAlD
Menadione—BGLAP—head—skin cancer	0.00116	0.00526	CbGeAlD
Menadione—GGCX—head—skin cancer	0.00113	0.00514	CbGeAlD
Menadione—NQO1—Validated transcriptional targets of TAp63 isoforms—SHH—skin cancer	0.00109	0.0146	CbGpPWpGaD
Menadione—PROS1—head—skin cancer	0.00108	0.00488	CbGeAlD
Menadione—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00106	0.0142	CbGpPWpGaD
Menadione—XDH—female reproductive system—skin cancer	0.00104	0.00472	CbGeAlD
Menadione—NQO1—connective tissue—skin cancer	0.00102	0.00463	CbGeAlD
Menadione—MAOB—nipple—skin cancer	0.00102	0.00462	CbGeAlD
Menadione—F10—head—skin cancer	0.00101	0.00459	CbGeAlD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—skin cancer	0.00101	0.0135	CbGpPWpGaD
Menadione—NQO2—mammalian vulva—skin cancer	0.001	0.00456	CbGeAlD
Menadione—VKORC1—head—skin cancer	0.000971	0.0044	CbGeAlD
Menadione—NQO1—epithelium—skin cancer	0.000969	0.0044	CbGeAlD
Menadione—PROZ—Metabolism of proteins—EXOC2—skin cancer	0.000929	0.0125	CbGpPWpGaD
Menadione—MTHFR—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000924	0.0124	CbGpPWpGaD
Menadione—NQO1—skin of body—skin cancer	0.000922	0.00418	CbGeAlD
Menadione—F2—lymphoid tissue—skin cancer	0.000895	0.00406	CbGeAlD
Menadione—MTHFR—lymphoid tissue—skin cancer	0.000895	0.00406	CbGeAlD
Menadione—MTHFR—female reproductive system—skin cancer	0.000863	0.00392	CbGeAlD
Menadione—F2—female reproductive system—skin cancer	0.000863	0.00392	CbGeAlD
Menadione—NQO2—female reproductive system—skin cancer	0.00086	0.0039	CbGeAlD
Menadione—NQO1—mammalian vulva—skin cancer	0.000841	0.00381	CbGeAlD
Menadione—BGLAP—Regulation of retinoblastoma protein—CDK4—skin cancer	0.000828	0.0112	CbGpPWpGaD
Menadione—GGCX—lymph node—skin cancer	0.000793	0.0036	CbGeAlD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.000781	0.0105	CbGpPWpGaD
Menadione—AOX1—mammalian vulva—skin cancer	0.000771	0.0035	CbGeAlD
Menadione—PROS1—lymph node—skin cancer	0.000753	0.00342	CbGeAlD
Menadione—F9—Metabolism of proteins—EXOC2—skin cancer	0.000725	0.00976	CbGpPWpGaD
Menadione—CYP1A2—nipple—skin cancer	0.000725	0.00329	CbGeAlD
Menadione—MAOB—connective tissue—skin cancer	0.000722	0.00327	CbGeAlD
Menadione—MTHFR—head—skin cancer	0.000721	0.00327	CbGeAlD
Menadione—F2—head—skin cancer	0.000721	0.00327	CbGeAlD
Menadione—NQO1—female reproductive system—skin cancer	0.00072	0.00327	CbGeAlD
Menadione—NQO2—head—skin cancer	0.000719	0.00326	CbGeAlD
Menadione—CYP1A1—nipple—skin cancer	0.000715	0.00324	CbGeAlD
Menadione—F10—lymph node—skin cancer	0.000709	0.00322	CbGeAlD
Menadione—Thalidomide—PTGS2—skin cancer	0.00069	1	CrCbGaD
Menadione—GGCX—Metabolism of proteins—EXOC2—skin cancer	0.000685	0.00922	CbGpPWpGaD
Menadione—VKORC1—lymph node—skin cancer	0.00068	0.00308	CbGeAlD
Menadione—AOX1—female reproductive system—skin cancer	0.000661	0.003	CbGeAlD
Menadione—F7—Metabolism of proteins—EXOC2—skin cancer	0.000636	0.00857	CbGpPWpGaD
Menadione—BGLAP—Regulation of retinoblastoma protein—CDKN2A—skin cancer	0.000633	0.00852	CbGpPWpGaD
Menadione—NQO1—head—skin cancer	0.000602	0.00273	CbGeAlD
Menadione—MAOB—mammalian vulva—skin cancer	0.000594	0.0027	CbGeAlD
Menadione—VKORC1—Metabolism of proteins—EXOC2—skin cancer	0.000567	0.00764	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—EXOC2—skin cancer	0.000533	0.00718	CbGpPWpGaD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	0.000512	0.0069	CbGpPWpGaD
Menadione—MAOB—female reproductive system—skin cancer	0.000509	0.00231	CbGeAlD
Menadione—MTHFR—lymph node—skin cancer	0.000505	0.00229	CbGeAlD
Menadione—NQO2—lymph node—skin cancer	0.000503	0.00228	CbGeAlD
Menadione—F7—Selenium Micronutrient Network—PTGS2—skin cancer	0.0005	0.00674	CbGpPWpGaD
Menadione—CYP1A1—epithelium—skin cancer	0.000481	0.00218	CbGeAlD
Menadione—PROS1—Metabolism of proteins—EXOC2—skin cancer	0.000472	0.00636	CbGpPWpGaD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—HRAS—skin cancer	0.000466	0.00628	CbGpPWpGaD
Menadione—CYP1A1—skin of body—skin cancer	0.000458	0.00208	CbGeAlD
Menadione—NQO1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.00043	0.00579	CbGpPWpGaD
Menadione—MAOB—head—skin cancer	0.000425	0.00193	CbGeAlD
Menadione—F7—Vitamin B12 Metabolism—IL6—skin cancer	0.000422	0.00568	CbGpPWpGaD
Menadione—NQO1—lymph node—skin cancer	0.000421	0.00191	CbGeAlD
Menadione—CYP1A1—mammalian vulva—skin cancer	0.000417	0.00189	CbGeAlD
Menadione—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—skin cancer	0.000405	0.00545	CbGpPWpGaD
Menadione—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	0.000398	0.00536	CbGpPWpGaD
Menadione—AOX1—lymph node—skin cancer	0.000386	0.00175	CbGeAlD
Menadione—F2—Peptide ligand-binding receptors—MC1R—skin cancer	0.000379	0.0051	CbGpPWpGaD
Menadione—F7—Folate Metabolism—TP53—skin cancer	0.000375	0.00505	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—TLR7—skin cancer	0.000374	0.00504	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000372	0.005	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—CDK4—skin cancer	0.000361	0.00487	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—EXOC2—skin cancer	0.00036	0.00484	CbGpPWpGaD
Menadione—CYP1A1—female reproductive system—skin cancer	0.000357	0.00162	CbGeAlD
Menadione—F7—Folate Metabolism—IL6—skin cancer	0.000343	0.00462	CbGpPWpGaD
Menadione—CYP2E1—lymphoid tissue—skin cancer	0.000338	0.00153	CbGeAlD
Menadione—NQO1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000335	0.00451	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	0.000332	0.00447	CbGpPWpGaD
Menadione—MTHFR—Fluoropyrimidine Activity—TP53—skin cancer	0.00033	0.00444	CbGpPWpGaD
Menadione—CYP2E1—female reproductive system—skin cancer	0.000326	0.00148	CbGeAlD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000325	0.00438	CbGpPWpGaD
Menadione—CYP1A1—head—skin cancer	0.000299	0.00135	CbGeAlD
Menadione—MAOB—lymph node—skin cancer	0.000298	0.00135	CbGeAlD
Menadione—PROC—Cell surface interactions at the vascular wall—NRAS—skin cancer	0.000297	0.004	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—TP53—skin cancer	0.000296	0.00399	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000288	0.00388	CbGpPWpGaD
Menadione—F7—Selenium Micronutrient Network—IL6—skin cancer	0.000273	0.00367	CbGpPWpGaD
Menadione—CYP2E1—head—skin cancer	0.000272	0.00124	CbGeAlD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.000271	0.00365	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—PTCH2—skin cancer	0.000268	0.0036	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—NRAS—skin cancer	0.000263	0.00354	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—KRAS—skin cancer	0.000255	0.00344	CbGpPWpGaD
Menadione—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	0.000255	0.00344	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000254	0.00342	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—PTGS2—skin cancer	0.000253	0.00341	CbGpPWpGaD
Menadione—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	0.000249	0.00336	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000245	0.0033	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—PTGS2—skin cancer	0.00023	0.00309	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—KRAS—skin cancer	0.000226	0.00304	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000224	0.00302	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—EXOC2—skin cancer	0.000221	0.00298	CbGpPWpGaD
Menadione—PROS1—Immune System—TLR7—skin cancer	0.000218	0.00294	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—HRAS—skin cancer	0.000217	0.00292	CbGpPWpGaD
Menadione—MTHFR—Vitamin B12 Metabolism—IL6—skin cancer	0.000213	0.00287	CbGpPWpGaD
Menadione—CYP1A1—lymph node—skin cancer	0.000209	0.000949	CbGeAlD
Menadione—F2—GPCR ligand binding—MC1R—skin cancer	0.000194	0.00261	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—FOXO4—skin cancer	0.000193	0.0026	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—HRAS—skin cancer	0.000192	0.00259	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TP53—skin cancer	0.000189	0.00255	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—PTGS2—skin cancer	0.000174	0.00234	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—IL6—skin cancer	0.000173	0.00234	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000167	0.00225	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RHOU—skin cancer	0.000166	0.00224	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TP53—skin cancer	0.000154	0.00207	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—IL6—skin cancer	0.000147	0.00198	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—BRAF—skin cancer	0.000141	0.0019	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—IL6—skin cancer	0.000141	0.0019	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—SHH—skin cancer	0.000138	0.00186	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—IL6—skin cancer	0.000138	0.00186	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PTCH2—skin cancer	0.000137	0.00185	CbGpPWpGaD
Menadione—NQO1—Metabolism—PLIN2—skin cancer	0.000134	0.00181	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	0.000133	0.00179	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PLIN2—skin cancer	0.000133	0.00179	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—PTCH1—skin cancer	0.000131	0.00176	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—SMO—skin cancer	0.000131	0.00176	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—skin cancer	0.00013	0.00176	CbGpPWpGaD
Menadione—AOX1—Metabolism—PLIN2—skin cancer	0.00013	0.00174	CbGpPWpGaD
Menadione—MTHFR—Disease—CSPG4—skin cancer	0.000128	0.00172	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000127	0.00171	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—PTGER4—skin cancer	0.000127	0.00171	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—IL6—skin cancer	0.000125	0.00168	CbGpPWpGaD
Menadione—AOX1—Disease—CSPG4—skin cancer	0.000125	0.00168	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—NRAS—skin cancer	0.000123	0.00166	CbGpPWpGaD
Menadione—XDH—Metabolism—PLIN2—skin cancer	0.00012	0.00162	CbGpPWpGaD
Menadione—F2—Folate Metabolism—IL6—skin cancer	0.000119	0.00161	CbGpPWpGaD
Menadione—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	0.000119	0.0016	CbGpPWpGaD
Menadione—PROS1—Immune System—FOXO4—skin cancer	0.000112	0.00151	CbGpPWpGaD
Menadione—MAOB—Metabolism—PLIN2—skin cancer	0.000109	0.00147	CbGpPWpGaD
Menadione—F9—Hemostasis—NRAS—skin cancer	0.000109	0.00147	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—MC1R—skin cancer	0.000109	0.00147	CbGpPWpGaD
Menadione—NQO1—Metabolism—CSPG4—skin cancer	0.000108	0.00146	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CSPG4—skin cancer	0.000107	0.00144	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—KRAS—skin cancer	0.000106	0.00143	CbGpPWpGaD
Menadione—AOX1—Metabolism—CSPG4—skin cancer	0.000104	0.00141	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—MC1R—skin cancer	9.93e-05	0.00134	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	9.9e-05	0.00133	CbGpPWpGaD
Menadione—XDH—Metabolism—CSPG4—skin cancer	9.71e-05	0.00131	CbGpPWpGaD
Menadione—F7—Hemostasis—NRAS—skin cancer	9.6e-05	0.00129	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—IL6—skin cancer	9.48e-05	0.00128	CbGpPWpGaD
Menadione—F9—Hemostasis—KRAS—skin cancer	9.41e-05	0.00127	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—HRAS—skin cancer	9.02e-05	0.00121	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.92e-05	0.0012	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—NRAS—skin cancer	8.89e-05	0.0012	CbGpPWpGaD
Menadione—MAOB—Metabolism—CSPG4—skin cancer	8.82e-05	0.00119	CbGpPWpGaD
Menadione—MTHFR—Disease—SHH—skin cancer	8.68e-05	0.00117	CbGpPWpGaD
Menadione—MTHFR—Disease—ENO2—skin cancer	8.68e-05	0.00117	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	8.52e-05	0.00115	CbGpPWpGaD
Menadione—AOX1—Disease—SHH—skin cancer	8.47e-05	0.00114	CbGpPWpGaD
Menadione—AOX1—Disease—ENO2—skin cancer	8.47e-05	0.00114	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—skin cancer	8.37e-05	0.00113	CbGpPWpGaD
Menadione—F7—Hemostasis—KRAS—skin cancer	8.27e-05	0.00111	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	8.12e-05	0.00109	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTCH2—skin cancer	8.12e-05	0.00109	CbGpPWpGaD
Menadione—PROC—Hemostasis—NRAS—skin cancer	8.05e-05	0.00108	CbGpPWpGaD
Menadione—F9—Hemostasis—HRAS—skin cancer	8e-05	0.00108	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—KRAS—skin cancer	7.65e-05	0.00103	CbGpPWpGaD
Menadione—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	7.59e-05	0.00102	CbGpPWpGaD
Menadione—NQO1—Metabolism—ENO2—skin cancer	7.36e-05	0.00099	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—skin cancer	7.35e-05	0.000989	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ENO2—skin cancer	7.27e-05	0.000978	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	7.25e-05	0.000976	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PTGER4—skin cancer	7.19e-05	0.000968	CbGpPWpGaD
Menadione—PROS1—Hemostasis—NRAS—skin cancer	7.12e-05	0.000959	CbGpPWpGaD
Menadione—AOX1—Metabolism—ENO2—skin cancer	7.1e-05	0.000956	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—SHH—skin cancer	7.08e-05	0.000953	CbGpPWpGaD
Menadione—MTHFR—Disease—FOXO4—skin cancer	7.07e-05	0.000952	CbGpPWpGaD
Menadione—F7—Hemostasis—HRAS—skin cancer	7.03e-05	0.000946	CbGpPWpGaD
Menadione—PROC—Hemostasis—KRAS—skin cancer	6.93e-05	0.000933	CbGpPWpGaD
Menadione—AOX1—Disease—FOXO4—skin cancer	6.91e-05	0.00093	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PTCH1—skin cancer	6.71e-05	0.000903	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—SMO—skin cancer	6.71e-05	0.000903	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	6.63e-05	0.000892	CbGpPWpGaD
Menadione—XDH—Metabolism—ENO2—skin cancer	6.6e-05	0.000888	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PTGER4—skin cancer	6.53e-05	0.000879	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—NRAS—skin cancer	6.41e-05	0.000863	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	6.32e-05	0.00085	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—skin cancer	6.16e-05	0.000829	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GLI2—skin cancer	6.15e-05	0.000828	CbGpPWpGaD
Menadione—PROS1—Hemostasis—KRAS—skin cancer	6.13e-05	0.000825	CbGpPWpGaD
Menadione—MAOB—Metabolism—ENO2—skin cancer	6e-05	0.000807	CbGpPWpGaD
Menadione—PROC—Hemostasis—HRAS—skin cancer	5.89e-05	0.000793	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MC1R—skin cancer	5.87e-05	0.00079	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GLI1—skin cancer	5.78e-05	0.000779	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	5.7e-05	0.000768	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.69e-05	0.000766	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—KRAS—skin cancer	5.52e-05	0.000743	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SUFU—skin cancer	5.48e-05	0.000738	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—skin cancer	5.45e-05	0.000734	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	5.44e-05	0.000732	CbGpPWpGaD
Menadione—F10—Hemostasis—NRAS—skin cancer	5.43e-05	0.000731	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PLIN2—skin cancer	5.33e-05	0.000718	CbGpPWpGaD
Menadione—PROS1—Hemostasis—HRAS—skin cancer	5.21e-05	0.000702	CbGpPWpGaD
Menadione—MTHFR—Disease—ERCC2—skin cancer	5.04e-05	0.000679	CbGpPWpGaD
Menadione—AOX1—Disease—ERCC2—skin cancer	4.92e-05	0.000663	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	4.85e-05	0.000653	CbGpPWpGaD
Menadione—MTHFR—Disease—TERT—skin cancer	4.72e-05	0.000636	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HRAS—skin cancer	4.69e-05	0.000632	CbGpPWpGaD
Menadione—F10—Hemostasis—KRAS—skin cancer	4.67e-05	0.000629	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	4.64e-05	0.000625	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.62e-05	0.000622	CbGpPWpGaD
Menadione—AOX1—Disease—TERT—skin cancer	4.61e-05	0.000621	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—IL6—skin cancer	4.49e-05	0.000605	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CSPG4—skin cancer	4.3e-05	0.000579	CbGpPWpGaD
Menadione—NQO1—Metabolism—ERCC2—skin cancer	4.27e-05	0.000575	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ERCC2—skin cancer	4.22e-05	0.000568	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PLIN2—skin cancer	4.21e-05	0.000567	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SHH—skin cancer	4.18e-05	0.000563	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RASA1—skin cancer	4.15e-05	0.000559	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—skin cancer	4.15e-05	0.000559	CbGpPWpGaD
Menadione—AOX1—Metabolism—ERCC2—skin cancer	4.12e-05	0.000555	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PLIN2—skin cancer	3.97e-05	0.000535	CbGpPWpGaD
Menadione—F10—Hemostasis—HRAS—skin cancer	3.97e-05	0.000535	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SMO—skin cancer	3.96e-05	0.000534	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTCH1—skin cancer	3.96e-05	0.000534	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTGER4—skin cancer	3.86e-05	0.00052	CbGpPWpGaD
Menadione—XDH—Metabolism—ERCC2—skin cancer	3.83e-05	0.000516	CbGpPWpGaD
Menadione—MTHFR—Disease—BRAF—skin cancer	3.74e-05	0.000504	CbGpPWpGaD
Menadione—PROS1—Immune System—NRAS—skin cancer	3.73e-05	0.000503	CbGpPWpGaD
Menadione—AOX1—Disease—BRAF—skin cancer	3.65e-05	0.000492	CbGpPWpGaD
Menadione—MAOB—Metabolism—ERCC2—skin cancer	3.48e-05	0.000469	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FOXO4—skin cancer	3.41e-05	0.000459	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CSPG4—skin cancer	3.4e-05	0.000457	CbGpPWpGaD
Menadione—F2—Hemostasis—NRAS—skin cancer	3.34e-05	0.00045	CbGpPWpGaD
Menadione—PROS1—Immune System—KRAS—skin cancer	3.21e-05	0.000433	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CSPG4—skin cancer	3.2e-05	0.000431	CbGpPWpGaD
Menadione—MTHFR—Disease—PTGS2—skin cancer	3.02e-05	0.000407	CbGpPWpGaD
Menadione—AOX1—Disease—PTGS2—skin cancer	2.95e-05	0.000397	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ENO2—skin cancer	2.92e-05	0.000393	CbGpPWpGaD
Menadione—F2—Hemostasis—KRAS—skin cancer	2.88e-05	0.000387	CbGpPWpGaD
Menadione—PROS1—Immune System—HRAS—skin cancer	2.73e-05	0.000368	CbGpPWpGaD
Menadione—PROS1—Immune System—IL6—skin cancer	2.61e-05	0.000352	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTGS2—skin cancer	2.56e-05	0.000345	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—skin cancer	2.56e-05	0.000344	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PLIN2—skin cancer	2.53e-05	0.000341	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTGS2—skin cancer	2.53e-05	0.000341	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTGS2—skin cancer	2.47e-05	0.000333	CbGpPWpGaD
Menadione—F2—Hemostasis—HRAS—skin cancer	2.44e-05	0.000329	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—skin cancer	2.35e-05	0.000317	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ENO2—skin cancer	2.31e-05	0.000311	CbGpPWpGaD
Menadione—XDH—Metabolism—PTGS2—skin cancer	2.3e-05	0.000309	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—skin cancer	2.3e-05	0.000309	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TERT—skin cancer	2.28e-05	0.000307	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ENO2—skin cancer	2.18e-05	0.000293	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTGS2—skin cancer	2.09e-05	0.000281	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CSPG4—skin cancer	2.04e-05	0.000275	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—skin cancer	2.02e-05	0.000272	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—skin cancer	1.98e-05	0.000266	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—skin cancer	1.92e-05	0.000258	CbGpPWpGaD
Menadione—F2—Signaling Pathways—BRAF—skin cancer	1.8e-05	0.000243	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—skin cancer	1.72e-05	0.000232	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.7e-05	0.000229	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ERCC2—skin cancer	1.7e-05	0.000228	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—skin cancer	1.68e-05	0.000226	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—skin cancer	1.65e-05	0.000222	CbGpPWpGaD
Menadione—MTHFR—Disease—IL6—skin cancer	1.65e-05	0.000222	CbGpPWpGaD
Menadione—AOX1—Disease—IL6—skin cancer	1.61e-05	0.000216	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—skin cancer	1.4e-05	0.000189	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ENO2—skin cancer	1.39e-05	0.000187	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6—skin cancer	1.34e-05	0.000181	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ERCC2—skin cancer	1.34e-05	0.000181	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ERCC2—skin cancer	1.26e-05	0.00017	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—skin cancer	1.13e-05	0.000153	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.09e-05	0.000146	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTGS2—skin cancer	1.02e-05	0.000137	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—skin cancer	9.75e-06	0.000131	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—skin cancer	8.67e-06	0.000117	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—skin cancer	8.29e-06	0.000112	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ERCC2—skin cancer	8.06e-06	0.000109	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTGS2—skin cancer	8.04e-06	0.000108	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6—skin cancer	7.93e-06	0.000107	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTGS2—skin cancer	7.58e-06	0.000102	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTGS2—skin cancer	4.83e-06	6.51e-05	CbGpPWpGaD
